Andrew Faughnan | Head, IR |
John Crowley | Chairman and CEO |
Bradley Campbell | President and COO |
Daphne Quimi | CFO |
Jeff Castelli | Chief Development Officer |
Mitchell Goldman | SVP, Clinical Research |
Ritu Baral | Cowen & Company |
Tazeen Ahmad | Bank of America |
Kristen Kluska | Cantor Fitzgerald |
Tessa Romero | JPMorgan |
Salveen Richter | Goldman Sachs |
Mohit Bansal | Citigroup |
Dae Gon Ha | Stifel Nicolaus |
Joseph Schwartz | SVB Leerink |
Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics First Quarter 2021 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mr.